<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146242">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01838486</url>
  </required_header>
  <id_info>
    <org_study_id>37/12</org_study_id>
    <nct_id>NCT01838486</nct_id>
  </id_info>
  <brief_title>Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome</brief_title>
  <acronym>IC</acronym>
  <official_title>Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with Interstitial Cystitis / PBS will be treated with bladder thermal distention
      (BTD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we will evaluate the efficacy of bladder thermal distention (BTD) in patients
      with IC/PBS.

      Patients with previous failed conventional treatment (intravesical DMSO) will be recruited.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>o'leary sant questionnaire</measure>
    <time_frame>up to 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>o'leary sant questionnaire is a validated specific tool for evaluation of IC/PBS symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bladder diary</measure>
    <time_frame>up to 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>symptoms like urgency. frequency and functional voided volumes will be monitored</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Interstitial Cystitis</condition>
  <condition>Painful Bladder Syndrome</condition>
  <arm_group>
    <arm_group_label>Bladder Thermal Distention (BTD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous irrigation of the bladder with warm saline (up to 45 Celsius) using the PelvixTT system</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bladder Thermal Distention</intervention_name>
    <description>Bladder Thermal Distention (BTD) is an approved procedure in Europe and Israel. Continuous irrigation of the bladder with warm saline with the PelvixTT system. The procedure will be performed on an outpatients basis. The procedure lasts 1 hour.</description>
    <arm_group_label>Bladder Thermal Distention (BTD)</arm_group_label>
    <other_name>PelvixTT - Hyperthermia Elmedical LTD, Israel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -All patients with interstitial cystitis / painful bladder syndrome (IC/PBS) who had
        previous intravesical treatment with DMSO

        Exclusion Criteria:

          -  Active infection

          -  Urethral stricture
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kobi Stav, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assaf Harofe Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kobi Stav, MD</last_name>
    <phone>972-8-9779409</phone>
    <email>stavkobi@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assaf Harofe Medical Center</name>
      <address>
        <city>Zerifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kobi Stav, MD</last_name>
      <email>stavkobi@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Kobi Stav, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 23, 2013</lastchanged_date>
  <firstreceived_date>April 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Interstitial cystitis</keyword>
  <keyword>painful bladder syndrome</keyword>
  <keyword>bladder hydrodistention</keyword>
  <keyword>hyperthermia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cystitis</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
    <mesh_term>Pain</mesh_term>
    <mesh_term>Cystitis, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
